BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 17376993)

  • 1. Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons.
    Mount MP; Lira A; Grimes D; Smith PD; Faucher S; Slack R; Anisman H; Hayley S; Park DS
    J Neurosci; 2007 Mar; 27(12):3328-37. PubMed ID: 17376993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    Hayley S; Crocker SJ; Smith PD; Shree T; Jackson-Lewis V; Przedborski S; Mount M; Slack R; Anisman H; Park DS
    J Neurosci; 2004 Feb; 24(8):2045-53. PubMed ID: 14985447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons.
    Gao HM; Liu B; Hong JS
    J Neurosci; 2003 Jul; 23(15):6181-7. PubMed ID: 12867501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
    Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T
    Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease.
    Kinugawa K; Monnet Y; Béchade C; Alvarez-Fischer D; Hirsch EC; Bessis A; Hunot S
    J Neuroinflammation; 2013 Jul; 10():82. PubMed ID: 23844828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of exosomes in dopaminergic neurodegeneration by microglial activation in midbrain slice cultures.
    Tsutsumi R; Hori Y; Seki T; Kurauchi Y; Sato M; Oshima M; Hisatsune A; Katsuki H
    Biochem Biophys Res Commun; 2019 Apr; 511(2):427-433. PubMed ID: 30803759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase.
    Wang Y; Liu D; Zhang H; Wang Y; Wei L; Liu Y; Liao J; Gao HM; Zhou H
    Toxicol Appl Pharmacol; 2017 May; 322():51-59. PubMed ID: 28283350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD200 Inhibits Inflammatory Response by Promoting KATP Channel Opening in Microglia Cells in Parkinson's Disease.
    Ren Y; Ye M; Chen S; Ding J
    Med Sci Monit; 2016 May; 22():1733-41. PubMed ID: 27213506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease.
    Depboylu C; Schorlemmer K; Klietz M; Oertel WH; Weihe E; Höglinger GU; Schäfer MK
    J Neuroimmunol; 2011 Jul; 236(1-2):39-46. PubMed ID: 21640391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel synthetic peptide SVHRSP attenuates dopaminergic neurodegeneration by inhibiting NADPH oxidase-mediated neuroinflammation in experimental models of Parkinson's disease.
    Zhang X; Tu D; Li S; Li N; Li D; Gao Y; Tian L; Liu J; Zhang X; Hong JS; Hou L; Zhao J; Wang Q
    Free Radic Biol Med; 2022 Aug; 188():363-374. PubMed ID: 35760232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation.
    Kim YS; Choi DH; Block ML; Lorenzl S; Yang L; Kim YJ; Sugama S; Cho BP; Hwang O; Browne SE; Kim SY; Hong JS; Beal MF; Joh TH
    FASEB J; 2007 Jan; 21(1):179-87. PubMed ID: 17116747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice.
    Sugama S; Yang L; Cho BP; DeGiorgio LA; Lorenzl S; Albers DS; Beal MF; Volpe BT; Joh TH
    Brain Res; 2003 Feb; 964(2):288-94. PubMed ID: 12576189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson's Disease Mouse Model.
    Ruan Z; Zhang D; Huang R; Sun W; Hou L; Zhao J; Wang Q
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
    FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death.
    Zhang W; Zecca L; Wilson B; Ren HW; Wang YJ; Wang XM; Hong JS
    Front Biosci (Elite Ed); 2013 Jan; 5(1):1-11. PubMed ID: 23276965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.